Pfizer and BioNTech announced on Tuesday that they had asked the US Food and Drug Administration (FDA) to authorize an additional booster dose of your covid-19 vaccine for people over 65 years of age.
Their claim is based on data from Israel and analyzed when the omicron variant was widely circulating, the companies said in a statement.
Read more: What is the IMSS Welfare for non-entitlers and how will it work?
These data show, according to Pfizer and BioNTech, that “an additional booster dose of the mRNA vaccine increases immunogenicity” (the ability to provoke an immune response) “and reduces rates of confirmed infections and severe illness.”
Therefore, the companies applied for an emergency use authorization from the FDA.
Mexico lowers travel alert to Mexico due to Covid-19
United States.- The United States Centers for Disease Control and Prevention (CDC) lowered the travel alert level for Mexico to three due to the Covid-19 pandemic.
In the update published this Monday, the CDC indicated that the risk of contracting SARS-CoV-2 in the Mexican Republic is “high”. The foregoing after last January of the current year, Mexico was placed at the highest level of risk due to the health contingency.
During the first month of this 2022, the CDC recommended that US citizens not travel to the national territory, due to the growing number of Covid-19 infections driven by the presence of the omicron variant.
Read more: Take care of your brain: These are the most recurrent myths about Alzheimer’s
#Pfizer #asks #United #States #booster #dose #Covid19